Sponsor or institution
Clinical trials and research at Akero Therapeutics, Inc
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Akero Therapeutics, Inc that are recruiting, at sites in 22 countries (most in Argentina (2), Australia (2), Canada (2)). By phase: Phase 3 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 22Countries
All recruiting trials (2)
-
Evaluating efruxifermin for patients with compensated cirrhosis due to NASH/MASH
This study is testing a new medication called efruxifermin to see if it can improve liver health in people with compensated cirrhosis caused by NASH or MASH.
-
Evaluating efruxifermin for treating NASH/MASH with fibrosis
This study is testing a new medication called efruxifermin to see if it can help people with NASH or MASH and liver fibrosis feel better compared to a placebo.
Quick answers
How many clinical trials run by Akero Therapeutics, Inc are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 22 countries. The most sites are in Argentina (2 trials), Australia (2 trials), Canada (2 trials), France (2 trials), Germany (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.